nodes	percent_of_prediction	percent_of_DWPC	metapath
Bezafibrate—SLCO1B1—Methotrexate—multiple sclerosis	0.09	0.167	CbGbCtD
Bezafibrate—CYP1A1—Dexamethasone—multiple sclerosis	0.0821	0.152	CbGbCtD
Bezafibrate—CYP3A4—Fingolimod—multiple sclerosis	0.0788	0.146	CbGbCtD
Bezafibrate—CYP3A4—Methylprednisolone—multiple sclerosis	0.0508	0.094	CbGbCtD
Bezafibrate—CYP2C8—Dexamethasone—multiple sclerosis	0.0474	0.0877	CbGbCtD
Bezafibrate—CYP3A4—Triamcinolone—multiple sclerosis	0.0385	0.0713	CbGbCtD
Bezafibrate—CYP3A4—Mitoxantrone—multiple sclerosis	0.0371	0.0686	CbGbCtD
Bezafibrate—CYP3A4—Betamethasone—multiple sclerosis	0.033	0.0611	CbGbCtD
Bezafibrate—CYP3A4—Prednisolone—multiple sclerosis	0.0326	0.0603	CbGbCtD
Bezafibrate—CYP3A4—Prednisone—multiple sclerosis	0.0308	0.057	CbGbCtD
Bezafibrate—CYP3A4—Dexamethasone—multiple sclerosis	0.0192	0.0356	CbGbCtD
Bezafibrate—PPARG—leg—multiple sclerosis	0.00919	0.189	CbGeAlD
Bezafibrate—PPARA—retina—multiple sclerosis	0.00376	0.0772	CbGeAlD
Bezafibrate—PPARD—midbrain—multiple sclerosis	0.00291	0.0599	CbGeAlD
Bezafibrate—Vascular purpura—Cladribine—multiple sclerosis	0.00268	0.0121	CcSEcCtD
Bezafibrate—Renal failure acute—Cladribine—multiple sclerosis	0.0026	0.0117	CcSEcCtD
Bezafibrate—Alopecia—Fingolimod—multiple sclerosis	0.00258	0.0117	CcSEcCtD
Bezafibrate—Purpura—Cladribine—multiple sclerosis	0.00249	0.0112	CcSEcCtD
Bezafibrate—PPARD—nervous system—multiple sclerosis	0.0024	0.0492	CbGeAlD
Bezafibrate—PPARD—central nervous system—multiple sclerosis	0.00231	0.0474	CbGeAlD
Bezafibrate—PPARD—cerebellum—multiple sclerosis	0.00225	0.0463	CbGeAlD
Bezafibrate—Toxic epidermal necrolysis—Cladribine—multiple sclerosis	0.00216	0.00975	CcSEcCtD
Bezafibrate—Muscular weakness—Cladribine—multiple sclerosis	0.00211	0.00955	CcSEcCtD
Bezafibrate—Infection—Fingolimod—multiple sclerosis	0.00206	0.00933	CcSEcCtD
Bezafibrate—PPARA—nervous system—multiple sclerosis	0.00204	0.0419	CbGeAlD
Bezafibrate—Pancytopenia—Cladribine—multiple sclerosis	0.00197	0.00889	CcSEcCtD
Bezafibrate—PPARA—central nervous system—multiple sclerosis	0.00197	0.0404	CbGeAlD
Bezafibrate—PPARA—cerebellum—multiple sclerosis	0.00192	0.0395	CbGeAlD
Bezafibrate—Glyburide—SLC15A2—multiple sclerosis	0.0019	0.688	CrCbGaD
Bezafibrate—PPARD—brain—multiple sclerosis	0.00183	0.0376	CbGeAlD
Bezafibrate—Stevens-Johnson syndrome—Cladribine—multiple sclerosis	0.00183	0.00827	CcSEcCtD
Bezafibrate—HMGCR—medulla oblongata—multiple sclerosis	0.00181	0.0371	CbGeAlD
Bezafibrate—Toxic epidermal necrolysis—Azathioprine—multiple sclerosis	0.00175	0.00793	CcSEcCtD
Bezafibrate—Renal failure acute—Mitoxantrone—multiple sclerosis	0.00171	0.00771	CcSEcCtD
Bezafibrate—HMGCR—midbrain—multiple sclerosis	0.00165	0.034	CbGeAlD
Bezafibrate—Pharyngitis—Cladribine—multiple sclerosis	0.00165	0.00744	CcSEcCtD
Bezafibrate—Urinary tract disorder—Cladribine—multiple sclerosis	0.00164	0.0074	CcSEcCtD
Bezafibrate—Urethral disorder—Cladribine—multiple sclerosis	0.00163	0.00734	CcSEcCtD
Bezafibrate—HMGCR—spinal cord—multiple sclerosis	0.00161	0.0331	CbGeAlD
Bezafibrate—Pancytopenia—Azathioprine—multiple sclerosis	0.0016	0.00723	CcSEcCtD
Bezafibrate—Erythema multiforme—Cladribine—multiple sclerosis	0.00157	0.00708	CcSEcCtD
Bezafibrate—PPARA—brain—multiple sclerosis	0.00156	0.0321	CbGeAlD
Bezafibrate—Stevens-Johnson syndrome—Azathioprine—multiple sclerosis	0.00149	0.00673	CcSEcCtD
Bezafibrate—Blood creatinine increased—Mitoxantrone—multiple sclerosis	0.00148	0.00667	CcSEcCtD
Bezafibrate—Pruritus—Fingolimod—multiple sclerosis	0.00147	0.00664	CcSEcCtD
Bezafibrate—Alopecia—Cladribine—multiple sclerosis	0.00146	0.00662	CcSEcCtD
Bezafibrate—Erythema—Cladribine—multiple sclerosis	0.00144	0.00652	CcSEcCtD
Bezafibrate—Flatulence—Cladribine—multiple sclerosis	0.00142	0.00643	CcSEcCtD
Bezafibrate—Diarrhoea—Fingolimod—multiple sclerosis	0.00142	0.00642	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Mitoxantrone—multiple sclerosis	0.00142	0.00641	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Mitoxantrone—multiple sclerosis	0.00139	0.00628	CcSEcCtD
Bezafibrate—Dizziness—Fingolimod—multiple sclerosis	0.00137	0.00621	CcSEcCtD
Bezafibrate—Blood alkaline phosphatase increased—Methylprednisolone—multiple sclerosis	0.00136	0.00616	CcSEcCtD
Bezafibrate—HMGCR—nervous system—multiple sclerosis	0.00136	0.0279	CbGeAlD
Bezafibrate—Anaemia—Cladribine—multiple sclerosis	0.00133	0.00603	CcSEcCtD
Bezafibrate—Vascular purpura—Triamcinolone—multiple sclerosis	0.00133	0.006	CcSEcCtD
Bezafibrate—HMGCR—central nervous system—multiple sclerosis	0.00131	0.0269	CbGeAlD
Bezafibrate—Headache—Fingolimod—multiple sclerosis	0.0013	0.00588	CcSEcCtD
Bezafibrate—Pancytopenia—Mitoxantrone—multiple sclerosis	0.00129	0.00584	CcSEcCtD
Bezafibrate—HMGCR—cerebellum—multiple sclerosis	0.00128	0.0263	CbGeAlD
Bezafibrate—Erythema multiforme—Azathioprine—multiple sclerosis	0.00127	0.00576	CcSEcCtD
Bezafibrate—Erectile dysfunction—Mitoxantrone—multiple sclerosis	0.00125	0.00567	CcSEcCtD
Bezafibrate—Purpura—Triamcinolone—multiple sclerosis	0.00123	0.00557	CcSEcCtD
Bezafibrate—Myalgia—Cladribine—multiple sclerosis	0.00123	0.00555	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Mitoxantrone—multiple sclerosis	0.0012	0.00541	CcSEcCtD
Bezafibrate—Alopecia—Azathioprine—multiple sclerosis	0.00119	0.00538	CcSEcCtD
Bezafibrate—Myocardial infarction—Mitoxantrone—multiple sclerosis	0.00119	0.00538	CcSEcCtD
Bezafibrate—Infection—Cladribine—multiple sclerosis	0.00117	0.00529	CcSEcCtD
Bezafibrate—Thrombocytopenia—Cladribine—multiple sclerosis	0.00115	0.00521	CcSEcCtD
Bezafibrate—Muscular weakness—Prednisolone—multiple sclerosis	0.00114	0.00515	CcSEcCtD
Bezafibrate—PPARG—nervous system—multiple sclerosis	0.00112	0.0231	CbGeAlD
Bezafibrate—Anaemia—Azathioprine—multiple sclerosis	0.00108	0.0049	CcSEcCtD
Bezafibrate—Pharyngitis—Mitoxantrone—multiple sclerosis	0.00108	0.00489	CcSEcCtD
Bezafibrate—PPARG—central nervous system—multiple sclerosis	0.00108	0.0222	CbGeAlD
Bezafibrate—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.00107	0.00485	CcSEcCtD
Bezafibrate—Insomnia—Cladribine—multiple sclerosis	0.00107	0.00481	CcSEcCtD
Bezafibrate—Migraine—Betamethasone—multiple sclerosis	0.00106	0.0048	CcSEcCtD
Bezafibrate—Migraine—Dexamethasone—multiple sclerosis	0.00106	0.0048	CcSEcCtD
Bezafibrate—Vascular purpura—Prednisone—multiple sclerosis	0.00105	0.00474	CcSEcCtD
Bezafibrate—Muscular weakness—Triamcinolone—multiple sclerosis	0.00105	0.00474	CcSEcCtD
Bezafibrate—Muscular weakness—Methylprednisolone—multiple sclerosis	0.00105	0.00473	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Methylprednisolone—multiple sclerosis	0.00105	0.00473	CcSEcCtD
Bezafibrate—HMGCR—brain—multiple sclerosis	0.00104	0.0213	CbGeAlD
Bezafibrate—Influenza—Triamcinolone—multiple sclerosis	0.00103	0.00464	CcSEcCtD
Bezafibrate—Pain—Cladribine—multiple sclerosis	0.00101	0.00455	CcSEcCtD
Bezafibrate—Constipation—Cladribine—multiple sclerosis	0.00101	0.00455	CcSEcCtD
Bezafibrate—Myalgia—Azathioprine—multiple sclerosis	0.000999	0.00451	CcSEcCtD
Bezafibrate—Bronchitis—Triamcinolone—multiple sclerosis	0.000988	0.00446	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Prednisolone—multiple sclerosis	0.000982	0.00444	CcSEcCtD
Bezafibrate—Myocardial infarction—Prednisolone—multiple sclerosis	0.000976	0.00441	CcSEcCtD
Bezafibrate—Purpura—Prednisone—multiple sclerosis	0.000974	0.0044	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000963	0.00435	CcSEcCtD
Bezafibrate—Alopecia—Mitoxantrone—multiple sclerosis	0.000963	0.00435	CcSEcCtD
Bezafibrate—Infection—Azathioprine—multiple sclerosis	0.000951	0.0043	CcSEcCtD
Bezafibrate—Muscular weakness—Dexamethasone—multiple sclerosis	0.000951	0.0043	CcSEcCtD
Bezafibrate—Muscular weakness—Betamethasone—multiple sclerosis	0.000951	0.0043	CcSEcCtD
Bezafibrate—Erythema—Mitoxantrone—multiple sclerosis	0.000949	0.00429	CcSEcCtD
Bezafibrate—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000938	0.00424	CcSEcCtD
Bezafibrate—Urticaria—Cladribine—multiple sclerosis	0.000936	0.00423	CcSEcCtD
Bezafibrate—Abdominal pain—Cladribine—multiple sclerosis	0.000931	0.00421	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Triamcinolone—multiple sclerosis	0.000903	0.00408	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Methylprednisolone—multiple sclerosis	0.000901	0.00407	CcSEcCtD
Bezafibrate—Myocardial infarction—Triamcinolone—multiple sclerosis	0.000898	0.00406	CcSEcCtD
Bezafibrate—Myocardial infarction—Methylprednisolone—multiple sclerosis	0.000896	0.00405	CcSEcCtD
Bezafibrate—Photosensitivity—Methotrexate—multiple sclerosis	0.000894	0.00404	CcSEcCtD
Bezafibrate—Anaemia—Mitoxantrone—multiple sclerosis	0.000877	0.00396	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000873	0.00394	CcSEcCtD
Bezafibrate—Hypersensitivity—Cladribine—multiple sclerosis	0.000868	0.00392	CcSEcCtD
Bezafibrate—PPARG—brain—multiple sclerosis	0.000858	0.0176	CbGeAlD
Bezafibrate—Renal failure acute—Methotrexate—multiple sclerosis	0.00085	0.00384	CcSEcCtD
Bezafibrate—Pruritus—Cladribine—multiple sclerosis	0.000833	0.00377	CcSEcCtD
Bezafibrate—Muscular weakness—Prednisone—multiple sclerosis	0.000828	0.00374	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Prednisone—multiple sclerosis	0.000828	0.00374	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Betamethasone—multiple sclerosis	0.000819	0.0037	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Dexamethasone—multiple sclerosis	0.000819	0.0037	CcSEcCtD
Bezafibrate—Pharyngitis—Triamcinolone—multiple sclerosis	0.000816	0.00369	CcSEcCtD
Bezafibrate—Myocardial infarction—Betamethasone—multiple sclerosis	0.000815	0.00368	CcSEcCtD
Bezafibrate—Myocardial infarction—Dexamethasone—multiple sclerosis	0.000815	0.00368	CcSEcCtD
Bezafibrate—Myalgia—Mitoxantrone—multiple sclerosis	0.000808	0.00365	CcSEcCtD
Bezafibrate—Diarrhoea—Cladribine—multiple sclerosis	0.000806	0.00364	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000783	0.00354	CcSEcCtD
Bezafibrate—Dizziness—Cladribine—multiple sclerosis	0.000779	0.00352	CcSEcCtD
Bezafibrate—Erythema—Prednisolone—multiple sclerosis	0.000778	0.00352	CcSEcCtD
Bezafibrate—Infection—Mitoxantrone—multiple sclerosis	0.000769	0.00348	CcSEcCtD
Bezafibrate—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000758	0.00343	CcSEcCtD
Bezafibrate—Abdominal pain—Azathioprine—multiple sclerosis	0.000757	0.00342	CcSEcCtD
Bezafibrate—Erectile dysfunction—Prednisone—multiple sclerosis	0.000747	0.00338	CcSEcCtD
Bezafibrate—Rash—Cladribine—multiple sclerosis	0.000743	0.00336	CcSEcCtD
Bezafibrate—Dermatitis—Cladribine—multiple sclerosis	0.000742	0.00335	CcSEcCtD
Bezafibrate—Headache—Cladribine—multiple sclerosis	0.000738	0.00333	CcSEcCtD
Bezafibrate—Liver function test abnormal—Methotrexate—multiple sclerosis	0.000725	0.00327	CcSEcCtD
Bezafibrate—Erythema—Triamcinolone—multiple sclerosis	0.000716	0.00323	CcSEcCtD
Bezafibrate—Erythema—Methylprednisolone—multiple sclerosis	0.000714	0.00323	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Prednisone—multiple sclerosis	0.000713	0.00322	CcSEcCtD
Bezafibrate—Myocardial infarction—Prednisone—multiple sclerosis	0.000709	0.00321	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.000707	0.00319	CcSEcCtD
Bezafibrate—Hypersensitivity—Azathioprine—multiple sclerosis	0.000706	0.00319	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000705	0.00319	CcSEcCtD
Bezafibrate—Nausea—Cladribine—multiple sclerosis	0.0007	0.00316	CcSEcCtD
Bezafibrate—CYP1A1—nervous system—multiple sclerosis	0.000683	0.014	CbGeAlD
Bezafibrate—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000681	0.00308	CcSEcCtD
Bezafibrate—Constipation—Mitoxantrone—multiple sclerosis	0.000662	0.00299	CcSEcCtD
Bezafibrate—Pain—Mitoxantrone—multiple sclerosis	0.000662	0.00299	CcSEcCtD
Bezafibrate—Alopecia—Betamethasone—multiple sclerosis	0.000659	0.00298	CcSEcCtD
Bezafibrate—Alopecia—Dexamethasone—multiple sclerosis	0.000659	0.00298	CcSEcCtD
Bezafibrate—CYP1A1—central nervous system—multiple sclerosis	0.000658	0.0135	CbGeAlD
Bezafibrate—Diarrhoea—Azathioprine—multiple sclerosis	0.000655	0.00296	CcSEcCtD
Bezafibrate—Erythema—Dexamethasone—multiple sclerosis	0.000649	0.00293	CcSEcCtD
Bezafibrate—Erythema—Betamethasone—multiple sclerosis	0.000649	0.00293	CcSEcCtD
Bezafibrate—Pancytopenia—Methotrexate—multiple sclerosis	0.000644	0.00291	CcSEcCtD
Bezafibrate—Dizziness—Azathioprine—multiple sclerosis	0.000633	0.00286	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000633	0.00286	CcSEcCtD
Bezafibrate—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000625	0.00282	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000619	0.0028	CcSEcCtD
Bezafibrate—Urticaria—Mitoxantrone—multiple sclerosis	0.000615	0.00278	CcSEcCtD
Bezafibrate—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000612	0.00277	CcSEcCtD
Bezafibrate—Myalgia—Triamcinolone—multiple sclerosis	0.000609	0.00275	CcSEcCtD
Bezafibrate—Myalgia—Methylprednisolone—multiple sclerosis	0.000608	0.00275	CcSEcCtD
Bezafibrate—Rash—Azathioprine—multiple sclerosis	0.000604	0.00273	CcSEcCtD
Bezafibrate—Dermatitis—Azathioprine—multiple sclerosis	0.000603	0.00273	CcSEcCtD
Bezafibrate—Headache—Azathioprine—multiple sclerosis	0.0006	0.00271	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.0006	0.00271	CcSEcCtD
Bezafibrate—Infection—Triamcinolone—multiple sclerosis	0.00058	0.00262	CcSEcCtD
Bezafibrate—Infection—Methylprednisolone—multiple sclerosis	0.000579	0.00262	CcSEcCtD
Bezafibrate—Insomnia—Prednisolone—multiple sclerosis	0.000574	0.0026	CcSEcCtD
Bezafibrate—Alopecia—Prednisone—multiple sclerosis	0.000574	0.00259	CcSEcCtD
Bezafibrate—PPARA—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000573	0.00307	CbGpPWpGaD
Bezafibrate—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00057	0.00258	CcSEcCtD
Bezafibrate—CYP1A1—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.00057	0.00305	CbGpPWpGaD
Bezafibrate—Nausea—Azathioprine—multiple sclerosis	0.000569	0.00257	CcSEcCtD
Bezafibrate—CYP2C8—brain—multiple sclerosis	0.000566	0.0116	CbGeAlD
Bezafibrate—Erythema—Prednisone—multiple sclerosis	0.000566	0.00256	CcSEcCtD
Bezafibrate—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—multiple sclerosis	0.000565	0.00302	CbGpPWpGaD
Bezafibrate—CYP1A1—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000562	0.003	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.00056	0.003	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.00056	0.003	CbGpPWpGaD
Bezafibrate—Myalgia—Dexamethasone—multiple sclerosis	0.000553	0.0025	CcSEcCtD
Bezafibrate—Myalgia—Betamethasone—multiple sclerosis	0.000553	0.0025	CcSEcCtD
Bezafibrate—Pain—Prednisolone—multiple sclerosis	0.000543	0.00245	CcSEcCtD
Bezafibrate—Pharyngitis—Methotrexate—multiple sclerosis	0.000539	0.00244	CcSEcCtD
Bezafibrate—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000536	0.00242	CcSEcCtD
Bezafibrate—Urethral disorder—Methotrexate—multiple sclerosis	0.000532	0.00241	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000532	0.0024	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000531	0.0024	CcSEcCtD
Bezafibrate—PPARG—Transcription factor regulation in adipogenesis—IL6—multiple sclerosis	0.00053	0.00283	CbGpPWpGaD
Bezafibrate—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00053	0.00239	CcSEcCtD
Bezafibrate—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000529	0.00283	CbGpPWpGaD
Bezafibrate—Insomnia—Triamcinolone—multiple sclerosis	0.000528	0.00239	CcSEcCtD
Bezafibrate—Insomnia—Methylprednisolone—multiple sclerosis	0.000527	0.00238	CcSEcCtD
Bezafibrate—Infection—Dexamethasone—multiple sclerosis	0.000527	0.00238	CcSEcCtD
Bezafibrate—Infection—Betamethasone—multiple sclerosis	0.000527	0.00238	CcSEcCtD
Bezafibrate—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—multiple sclerosis	0.000526	0.00281	CbGpPWpGaD
Bezafibrate—Anaemia—Prednisone—multiple sclerosis	0.000523	0.00236	CcSEcCtD
Bezafibrate—CYP1A1—brain—multiple sclerosis	0.000522	0.0107	CbGeAlD
Bezafibrate—PPARA—Adipogenesis—FAS—multiple sclerosis	0.000521	0.00279	CbGpPWpGaD
Bezafibrate—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000519	0.00234	CcSEcCtD
Bezafibrate—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000519	0.00234	CcSEcCtD
Bezafibrate—CYP1A1—Biological oxidations—CYP24A1—multiple sclerosis	0.000516	0.00276	CbGpPWpGaD
Bezafibrate—CYP1A1—Biological oxidations—CYP27B1—multiple sclerosis	0.000516	0.00276	CbGpPWpGaD
Bezafibrate—Dyspepsia—Triamcinolone—multiple sclerosis	0.000514	0.00232	CcSEcCtD
Bezafibrate—Erythema multiforme—Methotrexate—multiple sclerosis	0.000513	0.00232	CcSEcCtD
Bezafibrate—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000513	0.00232	CcSEcCtD
Bezafibrate—CYP1A1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000509	0.00272	CbGpPWpGaD
Bezafibrate—CYP1A1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000509	0.00272	CbGpPWpGaD
Bezafibrate—Urticaria—Prednisolone—multiple sclerosis	0.000505	0.00228	CcSEcCtD
Bezafibrate—PPARD—Ectoderm Differentiation—CCL2—multiple sclerosis	0.000503	0.00269	CbGpPWpGaD
Bezafibrate—CYP3A4—nervous system—multiple sclerosis	0.000501	0.0103	CbGeAlD
Bezafibrate—Pain—Triamcinolone—multiple sclerosis	0.000499	0.00226	CcSEcCtD
Bezafibrate—PPARA—Gene Expression—ZNF746—multiple sclerosis	0.000498	0.00266	CbGpPWpGaD
Bezafibrate—Rash—Mitoxantrone—multiple sclerosis	0.000488	0.00221	CcSEcCtD
Bezafibrate—Dermatitis—Mitoxantrone—multiple sclerosis	0.000488	0.0022	CcSEcCtD
Bezafibrate—Headache—Mitoxantrone—multiple sclerosis	0.000485	0.00219	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000483	0.00218	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000483	0.00218	CcSEcCtD
Bezafibrate—CYP3A4—central nervous system—multiple sclerosis	0.000483	0.00991	CbGeAlD
Bezafibrate—SLCO1B1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000482	0.00258	CbGpPWpGaD
Bezafibrate—Myalgia—Prednisone—multiple sclerosis	0.000481	0.00218	CcSEcCtD
Bezafibrate—Alopecia—Methotrexate—multiple sclerosis	0.00048	0.00217	CcSEcCtD
Bezafibrate—Insomnia—Betamethasone—multiple sclerosis	0.000479	0.00217	CcSEcCtD
Bezafibrate—Insomnia—Dexamethasone—multiple sclerosis	0.000479	0.00217	CcSEcCtD
Bezafibrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000478	0.00256	CbGpPWpGaD
Bezafibrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000478	0.00256	CbGpPWpGaD
Bezafibrate—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000477	0.00215	CcSEcCtD
Bezafibrate—CYP2C8—Biological oxidations—CYP27B1—multiple sclerosis	0.000473	0.00253	CbGpPWpGaD
Bezafibrate—CYP2C8—Biological oxidations—CYP24A1—multiple sclerosis	0.000473	0.00253	CbGpPWpGaD
Bezafibrate—Erythema—Methotrexate—multiple sclerosis	0.000473	0.00214	CcSEcCtD
Bezafibrate—Hypersensitivity—Prednisolone—multiple sclerosis	0.000468	0.00211	CcSEcCtD
Bezafibrate—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—multiple sclerosis	0.000467	0.0025	CbGpPWpGaD
Bezafibrate—CYP2C8—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000467	0.0025	CbGpPWpGaD
Bezafibrate—CYP2C8—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000467	0.0025	CbGpPWpGaD
Bezafibrate—Dyspepsia—Dexamethasone—multiple sclerosis	0.000467	0.00211	CcSEcCtD
Bezafibrate—Dyspepsia—Betamethasone—multiple sclerosis	0.000467	0.00211	CcSEcCtD
Bezafibrate—PPARD—Metabolism—SRM—multiple sclerosis	0.000465	0.00249	CbGpPWpGaD
Bezafibrate—Urticaria—Triamcinolone—multiple sclerosis	0.000464	0.0021	CcSEcCtD
Bezafibrate—Urticaria—Methylprednisolone—multiple sclerosis	0.000463	0.00209	CcSEcCtD
Bezafibrate—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000461	0.00208	CcSEcCtD
Bezafibrate—Nausea—Mitoxantrone—multiple sclerosis	0.00046	0.00208	CcSEcCtD
Bezafibrate—Infection—Prednisone—multiple sclerosis	0.000459	0.00207	CcSEcCtD
Bezafibrate—PPARA—Gene Expression—PTBP1—multiple sclerosis	0.000456	0.00244	CbGpPWpGaD
Bezafibrate—Pain—Dexamethasone—multiple sclerosis	0.000453	0.00205	CcSEcCtD
Bezafibrate—Pain—Betamethasone—multiple sclerosis	0.000453	0.00205	CcSEcCtD
Bezafibrate—PPARD—Gene Expression—U2AF2—multiple sclerosis	0.000453	0.00242	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—HNRNPA1—multiple sclerosis	0.000453	0.00242	CbGpPWpGaD
Bezafibrate—Indomethacin—ALB—multiple sclerosis	0.000452	0.164	CrCbGaD
Bezafibrate—Anaemia—Methotrexate—multiple sclerosis	0.000437	0.00197	CcSEcCtD
Bezafibrate—PPARA—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000434	0.00232	CbGpPWpGaD
Bezafibrate—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000433	0.00196	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000433	0.00196	CcSEcCtD
Bezafibrate—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00043	0.00194	CcSEcCtD
Bezafibrate—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000429	0.00194	CcSEcCtD
Bezafibrate—Urticaria—Betamethasone—multiple sclerosis	0.000421	0.0019	CcSEcCtD
Bezafibrate—Urticaria—Dexamethasone—multiple sclerosis	0.000421	0.0019	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.00042	0.0019	CcSEcCtD
Bezafibrate—Dizziness—Prednisolone—multiple sclerosis	0.00042	0.0019	CcSEcCtD
Bezafibrate—Abdominal pain—Betamethasone—multiple sclerosis	0.000419	0.00189	CcSEcCtD
Bezafibrate—Abdominal pain—Dexamethasone—multiple sclerosis	0.000419	0.00189	CcSEcCtD
Bezafibrate—Insomnia—Prednisone—multiple sclerosis	0.000417	0.00189	CcSEcCtD
Bezafibrate—Pruritus—Triamcinolone—multiple sclerosis	0.000413	0.00187	CcSEcCtD
Bezafibrate—Pruritus—Methylprednisolone—multiple sclerosis	0.000412	0.00186	CcSEcCtD
Bezafibrate—PPARD—Generic Transcription Pathway—PGR—multiple sclerosis	0.00041	0.00219	CbGpPWpGaD
Bezafibrate—Glyburide—ALB—multiple sclerosis	0.000408	0.148	CrCbGaD
Bezafibrate—Dyspepsia—Prednisone—multiple sclerosis	0.000406	0.00184	CcSEcCtD
Bezafibrate—Myalgia—Methotrexate—multiple sclerosis	0.000402	0.00182	CcSEcCtD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000402	0.00215	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000402	0.00215	CbGpPWpGaD
Bezafibrate—Rash—Prednisolone—multiple sclerosis	0.0004	0.00181	CcSEcCtD
Bezafibrate—Dermatitis—Prednisolone—multiple sclerosis	0.0004	0.00181	CcSEcCtD
Bezafibrate—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000399	0.0018	CcSEcCtD
Bezafibrate—Headache—Prednisolone—multiple sclerosis	0.000398	0.0018	CcSEcCtD
Bezafibrate—Constipation—Prednisone—multiple sclerosis	0.000395	0.00178	CcSEcCtD
Bezafibrate—HMGCR—Metabolism—SRM—multiple sclerosis	0.000387	0.00207	CbGpPWpGaD
Bezafibrate—Dizziness—Triamcinolone—multiple sclerosis	0.000386	0.00175	CcSEcCtD
Bezafibrate—Dizziness—Methylprednisolone—multiple sclerosis	0.000385	0.00174	CcSEcCtD
Bezafibrate—Infection—Methotrexate—multiple sclerosis	0.000383	0.00173	CcSEcCtD
Bezafibrate—PPARD—Wnt Signaling Pathway and Pluripotency—MYC—multiple sclerosis	0.000378	0.00202	CbGpPWpGaD
Bezafibrate—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000378	0.00171	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000377	0.00171	CcSEcCtD
Bezafibrate—Nausea—Prednisolone—multiple sclerosis	0.000377	0.0017	CcSEcCtD
Bezafibrate—Pruritus—Dexamethasone—multiple sclerosis	0.000375	0.00169	CcSEcCtD
Bezafibrate—Pruritus—Betamethasone—multiple sclerosis	0.000375	0.00169	CcSEcCtD
Bezafibrate—PPARG—Adipogenesis—FAS—multiple sclerosis	0.000373	0.002	CbGpPWpGaD
Bezafibrate—Rash—Triamcinolone—multiple sclerosis	0.000368	0.00166	CcSEcCtD
Bezafibrate—Dermatitis—Triamcinolone—multiple sclerosis	0.000368	0.00166	CcSEcCtD
Bezafibrate—PPARA—Circadian rythm related genes—FAS—multiple sclerosis	0.000368	0.00197	CbGpPWpGaD
Bezafibrate—Rash—Methylprednisolone—multiple sclerosis	0.000367	0.00166	CcSEcCtD
Bezafibrate—Dermatitis—Methylprednisolone—multiple sclerosis	0.000367	0.00166	CcSEcCtD
Bezafibrate—Urticaria—Prednisone—multiple sclerosis	0.000367	0.00166	CcSEcCtD
Bezafibrate—Headache—Triamcinolone—multiple sclerosis	0.000366	0.00165	CcSEcCtD
Bezafibrate—Headache—Methylprednisolone—multiple sclerosis	0.000365	0.00165	CcSEcCtD
Bezafibrate—Abdominal pain—Prednisone—multiple sclerosis	0.000365	0.00165	CcSEcCtD
Bezafibrate—Diarrhoea—Dexamethasone—multiple sclerosis	0.000363	0.00164	CcSEcCtD
Bezafibrate—Diarrhoea—Betamethasone—multiple sclerosis	0.000363	0.00164	CcSEcCtD
Bezafibrate—PPARA—Developmental Biology—PRNP—multiple sclerosis	0.00036	0.00193	CbGpPWpGaD
Bezafibrate—PPARA—Transcriptional regulation of white adipocyte differentiation—TGFB1—multiple sclerosis	0.00036	0.00193	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—ZFP36L1—multiple sclerosis	0.000358	0.00192	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—ZNF746—multiple sclerosis	0.000357	0.00191	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—SRM—multiple sclerosis	0.000354	0.00189	CbGpPWpGaD
Bezafibrate—PPARG—Wnt Signaling Pathway Netpath—MYC—multiple sclerosis	0.000354	0.00189	CbGpPWpGaD
Bezafibrate—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000351	0.00159	CcSEcCtD
Bezafibrate—Dizziness—Dexamethasone—multiple sclerosis	0.00035	0.00158	CcSEcCtD
Bezafibrate—Dizziness—Betamethasone—multiple sclerosis	0.00035	0.00158	CcSEcCtD
Bezafibrate—Insomnia—Methotrexate—multiple sclerosis	0.000349	0.00158	CcSEcCtD
Bezafibrate—Nausea—Triamcinolone—multiple sclerosis	0.000347	0.00157	CcSEcCtD
Bezafibrate—PPARG—Wnt Signaling Pathway Netpath—MAPK1—multiple sclerosis	0.000346	0.00185	CbGpPWpGaD
Bezafibrate—Nausea—Methylprednisolone—multiple sclerosis	0.000346	0.00156	CcSEcCtD
Bezafibrate—PPARA—Gene Expression—HNRNPA1—multiple sclerosis	0.000345	0.00185	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—U2AF2—multiple sclerosis	0.000345	0.00185	CbGpPWpGaD
Bezafibrate—PPARA—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000343	0.00184	CbGpPWpGaD
Bezafibrate—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—multiple sclerosis	0.00034	0.00182	CbGpPWpGaD
Bezafibrate—Hypersensitivity—Prednisone—multiple sclerosis	0.00034	0.00154	CcSEcCtD
Bezafibrate—Dyspepsia—Methotrexate—multiple sclerosis	0.00034	0.00153	CcSEcCtD
Bezafibrate—SLCO1B1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000337	0.0018	CbGpPWpGaD
Bezafibrate—PPARA—Transcriptional regulation of white adipocyte differentiation—TNF—multiple sclerosis	0.000336	0.0018	CbGpPWpGaD
Bezafibrate—PPARD—Adipogenesis—STAT3—multiple sclerosis	0.000335	0.00179	CbGpPWpGaD
Bezafibrate—Rash—Betamethasone—multiple sclerosis	0.000334	0.00151	CcSEcCtD
Bezafibrate—Rash—Dexamethasone—multiple sclerosis	0.000334	0.00151	CcSEcCtD
Bezafibrate—Dermatitis—Betamethasone—multiple sclerosis	0.000334	0.00151	CcSEcCtD
Bezafibrate—Dermatitis—Dexamethasone—multiple sclerosis	0.000334	0.00151	CcSEcCtD
Bezafibrate—Headache—Betamethasone—multiple sclerosis	0.000332	0.0015	CcSEcCtD
Bezafibrate—Headache—Dexamethasone—multiple sclerosis	0.000332	0.0015	CcSEcCtD
Bezafibrate—Pain—Methotrexate—multiple sclerosis	0.00033	0.00149	CcSEcCtD
Bezafibrate—PPARD—Metabolism—CYP24A1—multiple sclerosis	0.000328	0.00175	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—CYP27B1—multiple sclerosis	0.000328	0.00175	CbGpPWpGaD
Bezafibrate—Pruritus—Prednisone—multiple sclerosis	0.000327	0.00148	CcSEcCtD
Bezafibrate—PPARG—Gene Expression—PTBP1—multiple sclerosis	0.000326	0.00175	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000323	0.00173	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.00032	0.00171	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000316	0.00169	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000316	0.00169	CbGpPWpGaD
Bezafibrate—Diarrhoea—Prednisone—multiple sclerosis	0.000316	0.00143	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000315	0.00143	CcSEcCtD
Bezafibrate—Nausea—Betamethasone—multiple sclerosis	0.000315	0.00142	CcSEcCtD
Bezafibrate—Nausea—Dexamethasone—multiple sclerosis	0.000315	0.00142	CcSEcCtD
Bezafibrate—PPARA—Generic Transcription Pathway—PGR—multiple sclerosis	0.000312	0.00167	CbGpPWpGaD
Bezafibrate—PPARD—Adipogenesis—TGFB1—multiple sclerosis	0.000311	0.00166	CbGpPWpGaD
Bezafibrate—Urticaria—Methotrexate—multiple sclerosis	0.000306	0.00138	CcSEcCtD
Bezafibrate—Dizziness—Prednisone—multiple sclerosis	0.000305	0.00138	CcSEcCtD
Bezafibrate—Abdominal pain—Methotrexate—multiple sclerosis	0.000305	0.00138	CcSEcCtD
Bezafibrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000304	0.00163	CbGpPWpGaD
Bezafibrate—PPARA—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000304	0.00162	CbGpPWpGaD
Bezafibrate—PPARG—Signaling events mediated by HDAC Class I—STAT3—multiple sclerosis	0.0003	0.00161	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—GPC5—multiple sclerosis	0.0003	0.0016	CbGpPWpGaD
Bezafibrate—PPARD—Ectoderm Differentiation—MYC—multiple sclerosis	0.000297	0.00159	CbGpPWpGaD
Bezafibrate—Rash—Prednisone—multiple sclerosis	0.000291	0.00132	CcSEcCtD
Bezafibrate—Dermatitis—Prednisone—multiple sclerosis	0.000291	0.00131	CcSEcCtD
Bezafibrate—PPARD—Adipogenesis—TNF—multiple sclerosis	0.00029	0.00155	CbGpPWpGaD
Bezafibrate—Headache—Prednisone—multiple sclerosis	0.000289	0.00131	CcSEcCtD
Bezafibrate—PPARD—Generic Transcription Pathway—VDR—multiple sclerosis	0.000286	0.00153	CbGpPWpGaD
Bezafibrate—Hypersensitivity—Methotrexate—multiple sclerosis	0.000284	0.00128	CcSEcCtD
Bezafibrate—PPARD—NRF2 pathway—TGFB1—multiple sclerosis	0.000283	0.00152	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—PTPRC—multiple sclerosis	0.00028	0.0015	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—PABPC1—multiple sclerosis	0.000278	0.00149	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	0.000277	0.00148	CbGpPWpGaD
Bezafibrate—Nausea—Prednisone—multiple sclerosis	0.000274	0.00124	CcSEcCtD
Bezafibrate—PPARA—Gene Expression—ZFP36L1—multiple sclerosis	0.000273	0.00146	CbGpPWpGaD
Bezafibrate—Pruritus—Methotrexate—multiple sclerosis	0.000273	0.00123	CcSEcCtD
Bezafibrate—HMGCR—Metabolism—CYP24A1—multiple sclerosis	0.000273	0.00146	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—CYP27B1—multiple sclerosis	0.000273	0.00146	CbGpPWpGaD
Bezafibrate—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.00027	0.00144	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000267	0.00143	CbGpPWpGaD
Bezafibrate—Diarrhoea—Methotrexate—multiple sclerosis	0.000264	0.00119	CcSEcCtD
Bezafibrate—PPARG—Circadian rythm related genes—FAS—multiple sclerosis	0.000263	0.00141	CbGpPWpGaD
Bezafibrate—PPARG—Signaling events mediated by HDAC Class I—TNF—multiple sclerosis	0.00026	0.00139	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—PRNP—multiple sclerosis	0.000258	0.00138	CbGpPWpGaD
Bezafibrate—PPARG—Transcriptional regulation of white adipocyte differentiation—TGFB1—multiple sclerosis	0.000258	0.00138	CbGpPWpGaD
Bezafibrate—PPARA—Adipogenesis—STAT3—multiple sclerosis	0.000256	0.00137	CbGpPWpGaD
Bezafibrate—Dizziness—Methotrexate—multiple sclerosis	0.000255	0.00115	CcSEcCtD
Bezafibrate—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000254	0.00136	CbGpPWpGaD
Bezafibrate—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000254	0.00136	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—SRM—multiple sclerosis	0.000254	0.00136	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—RPL5—multiple sclerosis	0.000251	0.00134	CbGpPWpGaD
Bezafibrate—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000251	0.00134	CbGpPWpGaD
Bezafibrate—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000251	0.00134	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—CYP27B1—multiple sclerosis	0.00025	0.00133	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—GPC5—multiple sclerosis	0.00025	0.00133	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—CYP24A1—multiple sclerosis	0.00025	0.00133	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—RRM1—multiple sclerosis	0.000248	0.00133	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	0.000248	0.00132	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—U2AF2—multiple sclerosis	0.000247	0.00132	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—HNRNPA1—multiple sclerosis	0.000247	0.00132	CbGpPWpGaD
Bezafibrate—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000247	0.00132	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	0.000247	0.00132	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000245	0.00131	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000244	0.0013	CbGpPWpGaD
Bezafibrate—Rash—Methotrexate—multiple sclerosis	0.000243	0.0011	CcSEcCtD
Bezafibrate—Dermatitis—Methotrexate—multiple sclerosis	0.000243	0.0011	CcSEcCtD
Bezafibrate—Headache—Methotrexate—multiple sclerosis	0.000242	0.00109	CcSEcCtD
Bezafibrate—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—multiple sclerosis	0.000241	0.00129	CbGpPWpGaD
Bezafibrate—PPARA—Adipogenesis—TGFB1—multiple sclerosis	0.000237	0.00127	CbGpPWpGaD
Bezafibrate—PPARD—Adipogenesis—IL6—multiple sclerosis	0.000234	0.00125	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	0.00023	0.00123	CbGpPWpGaD
Bezafibrate—Nausea—Methotrexate—multiple sclerosis	0.000229	0.00104	CcSEcCtD
Bezafibrate—PPARA—Metabolism—GPC5—multiple sclerosis	0.000228	0.00122	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	0.000225	0.0012	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—PGR—multiple sclerosis	0.000224	0.0012	CbGpPWpGaD
Bezafibrate—PPARA—Adipogenesis—TNF—multiple sclerosis	0.000221	0.00118	CbGpPWpGaD
Bezafibrate—CYP1A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000219	0.00117	CbGpPWpGaD
Bezafibrate—PPARA—Generic Transcription Pathway—VDR—multiple sclerosis	0.000218	0.00117	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—PABPC1—multiple sclerosis	0.000212	0.00113	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—RRM1—multiple sclerosis	0.000207	0.00111	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—PTPRC—multiple sclerosis	0.000201	0.00107	CbGpPWpGaD
Bezafibrate—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.0002	0.00107	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—SRM—multiple sclerosis	0.0002	0.00107	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000198	0.00106	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000198	0.00106	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—PGR—multiple sclerosis	0.000197	0.00105	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—ZFP36L1—multiple sclerosis	0.000196	0.00105	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000194	0.00104	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	0.000193	0.00103	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000193	0.00103	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	0.000192	0.00103	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—RPL5—multiple sclerosis	0.000191	0.00102	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—RRM1—multiple sclerosis	0.000189	0.00101	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	0.000189	0.00101	CbGpPWpGaD
Bezafibrate—PPARG—Adipogenesis—STAT3—multiple sclerosis	0.000183	0.000979	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000182	0.000972	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000182	0.000972	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	0.00018	0.00096	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	0.00018	0.00096	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CYP27B1—multiple sclerosis	0.000179	0.000957	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CYP24A1—multiple sclerosis	0.000179	0.000957	CbGpPWpGaD
Bezafibrate—PPARA—Adipogenesis—IL6—multiple sclerosis	0.000178	0.000954	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000175	0.000935	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000171	0.000916	CbGpPWpGaD
Bezafibrate—PPARG—Adipogenesis—TGFB1—multiple sclerosis	0.00017	0.000908	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000165	0.000885	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GPC5—multiple sclerosis	0.000164	0.000875	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.00016	0.000858	CbGpPWpGaD
Bezafibrate—PPARG—Adipogenesis—TNF—multiple sclerosis	0.000158	0.000848	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—VDR—multiple sclerosis	0.000156	0.000836	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—PABPC1—multiple sclerosis	0.000152	0.000811	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000151	0.000807	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—PGR—multiple sclerosis	0.00015	0.000804	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000147	0.000785	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—BCHE—multiple sclerosis	0.000143	0.000763	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CYP24A1—multiple sclerosis	0.000141	0.000753	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CYP27B1—multiple sclerosis	0.000141	0.000753	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000138	0.000737	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—VDR—multiple sclerosis	0.000138	0.000737	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000138	0.000736	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—RPL5—multiple sclerosis	0.000137	0.000732	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—RRM1—multiple sclerosis	0.000136	0.000725	CbGpPWpGaD
Bezafibrate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000133	0.00071	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GPC5—multiple sclerosis	0.000129	0.000689	CbGpPWpGaD
Bezafibrate—PPARG—Adipogenesis—IL6—multiple sclerosis	0.000128	0.000684	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000126	0.000674	CbGpPWpGaD
Bezafibrate—PPARA—Circadian rythm related genes—IL6—multiple sclerosis	0.000126	0.000674	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000126	0.000672	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—TYK2—multiple sclerosis	0.000125	0.000671	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—SRM—multiple sclerosis	0.000125	0.00067	CbGpPWpGaD
Bezafibrate—SLCO1B1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000121	0.000649	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—BCHE—multiple sclerosis	0.000119	0.000635	CbGpPWpGaD
Bezafibrate—CYP1A1—Biological oxidations—POMC—multiple sclerosis	0.000116	0.000621	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000115	0.000615	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—SRM—multiple sclerosis	0.000115	0.000614	CbGpPWpGaD
Bezafibrate—PPARD—Generic Transcription Pathway—MYC—multiple sclerosis	0.000114	0.000609	CbGpPWpGaD
Bezafibrate—PPARA—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000109	0.000584	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—BCHE—multiple sclerosis	0.000109	0.000581	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—PGR—multiple sclerosis	0.000108	0.000576	CbGpPWpGaD
Bezafibrate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000108	0.000575	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—RRM1—multiple sclerosis	0.000107	0.000571	CbGpPWpGaD
Bezafibrate—CYP2C8—Biological oxidations—POMC—multiple sclerosis	0.000106	0.000569	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000105	0.000562	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—VDR—multiple sclerosis	0.000105	0.000562	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—MMP9—multiple sclerosis	9.88e-05	0.000528	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.03e-05	0.000483	CbGpPWpGaD
Bezafibrate—PPARG—Circadian rythm related genes—IL6—multiple sclerosis	9.03e-05	0.000483	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—TYK2—multiple sclerosis	8.99e-05	0.000481	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CYP27B1—multiple sclerosis	8.83e-05	0.000472	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CYP24A1—multiple sclerosis	8.83e-05	0.000472	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—STAT3—multiple sclerosis	8.78e-05	0.00047	CbGpPWpGaD
Bezafibrate—PPARA—Generic Transcription Pathway—MYC—multiple sclerosis	8.67e-05	0.000464	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	8.63e-05	0.000461	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—APOE—multiple sclerosis	8.58e-05	0.000459	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.28e-05	0.000443	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.24e-05	0.000441	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—TGFB1—multiple sclerosis	8.14e-05	0.000435	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	8.09e-05	0.000433	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	8.09e-05	0.000433	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GPC5—multiple sclerosis	8.07e-05	0.000432	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—MAPK1—multiple sclerosis	7.98e-05	0.000427	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	7.91e-05	0.000423	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—BCHE—multiple sclerosis	7.79e-05	0.000416	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—TNF—multiple sclerosis	7.6e-05	0.000407	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—VDR—multiple sclerosis	7.53e-05	0.000402	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GPC5—multiple sclerosis	7.4e-05	0.000396	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—POMC—multiple sclerosis	7.37e-05	0.000394	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—APOE—multiple sclerosis	7.15e-05	0.000382	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.11e-05	0.00038	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—MMP9—multiple sclerosis	7.08e-05	0.000379	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—ALB—multiple sclerosis	6.72e-05	0.000359	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—RRM1—multiple sclerosis	6.69e-05	0.000358	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—APOE—multiple sclerosis	6.54e-05	0.00035	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.49e-05	0.000347	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—STAT3—multiple sclerosis	6.29e-05	0.000337	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—MYC—multiple sclerosis	6.21e-05	0.000332	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.17e-05	0.00033	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SRM—multiple sclerosis	6.17e-05	0.00033	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—POMC—multiple sclerosis	6.14e-05	0.000328	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—IL6—multiple sclerosis	6.13e-05	0.000328	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—RRM1—multiple sclerosis	6.13e-05	0.000328	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—BCHE—multiple sclerosis	6.13e-05	0.000328	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—TGFB1—multiple sclerosis	5.83e-05	0.000312	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—MAPK1—multiple sclerosis	5.72e-05	0.000306	CbGpPWpGaD
Bezafibrate—CYP3A4—Biological oxidations—POMC—multiple sclerosis	5.71e-05	0.000306	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—POMC—multiple sclerosis	5.61e-05	0.0003	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—ALB—multiple sclerosis	5.6e-05	0.000299	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—MYC—multiple sclerosis	5.48e-05	0.000293	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—TNF—multiple sclerosis	5.45e-05	0.000291	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.19e-05	0.000278	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—ALB—multiple sclerosis	5.12e-05	0.000274	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.76e-05	0.000255	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—APOE—multiple sclerosis	4.68e-05	0.00025	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.46e-05	0.000238	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—IL6—multiple sclerosis	4.4e-05	0.000235	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	4.34e-05	0.000232	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	4.34e-05	0.000232	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—MYC—multiple sclerosis	4.17e-05	0.000223	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.09e-05	0.000219	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	4.07e-05	0.000217	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—POMC—multiple sclerosis	4.02e-05	0.000215	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GPC5—multiple sclerosis	3.97e-05	0.000212	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—BCHE—multiple sclerosis	3.84e-05	0.000206	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.73e-05	0.000199	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—APOE—multiple sclerosis	3.69e-05	0.000197	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ALB—multiple sclerosis	3.67e-05	0.000196	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—BCHE—multiple sclerosis	3.52e-05	0.000188	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—RRM1—multiple sclerosis	3.29e-05	0.000176	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—POMC—multiple sclerosis	3.17e-05	0.000169	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—MYC—multiple sclerosis	2.99e-05	0.00016	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ALB—multiple sclerosis	2.89e-05	0.000154	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—APOE—multiple sclerosis	2.31e-05	0.000124	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—APOE—multiple sclerosis	2.12e-05	0.000113	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—POMC—multiple sclerosis	1.99e-05	0.000106	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.89e-05	0.000101	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—POMC—multiple sclerosis	1.82e-05	9.74e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ALB—multiple sclerosis	1.81e-05	9.68e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ALB—multiple sclerosis	1.66e-05	8.88e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—APOE—multiple sclerosis	1.14e-05	6.08e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—POMC—multiple sclerosis	9.77e-06	5.23e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ALB—multiple sclerosis	8.91e-06	4.76e-05	CbGpPWpGaD
